DOI:
10.1055/s-00000036
Laryngo-Rhino-Otologie
LinksClose Window
References
Doebele RC, Drilon A, Paz-Ares L. et al.
Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trials.
Lancet Oncol 2020;
21 (02) 271-282
DOI: 10.1016/S1470-2045(19)30691-6. (PMID: 31838007)
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.